Aviva
AGN

Aviva’s Allergan plc AGN Stock Holding History

Aviva’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-36,000
Closed -$1.18M – 805
2016
Q2 		$1.18M Buy
+36,000
New +$8.3M 0.01% 701

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Aviva's AGN Position: Q2 2020 in Review

Aviva sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 206,322 shares — an estimated $36.5M sold.

Aviva first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $75.2M in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Aviva reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Aviva sold 206,322 Allergan plc shares in Q2 2020, an estimated $36.5M.
  • Aviva first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Aviva's Allergan plc position peaked at $75.2M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Aviva's 13F filing for Q2 2020, filed 13 Aug 2020.